Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 4500-4599

4500. N. de Jong, L. Hoff, T. Skotland, L. Bom, “Absorption and scatter of encapsulated gas filled microbubbles: theoretical considerations and some measurements,” Ultrasonics 30(1992):95-103.

4501. J.L. Barnhart, H.B. Levene, R. Keen, C. Saravis, J. Maniquis, E. Villapando, “Albunex microsphere shells, the unique feature of a new ultrasound contrast agent,” in H. Katayama, R.C. Brasch, eds., New Dimensions of Contrast Media, Excerpta Medica, Amsterdam, 1991.

4502. F.B. Feinstein, J. Cheirif, F.J. ten Cate, P.R. Silverman, P.A. Heidenreich, C. Dick, R.M. Desir, W.F. Armstrong, M.A. Quinones, P.M. Shah, “Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results,” J. Am. Coll. Cardiol. 16(1990):316-324.

4503. Peter Wells, “Chapter 7. Ultrasonic Contrast Agents, “ in Richard R.H. Coombs, Dennis W. Robinson, eds., Nanotechnology in Medicine and the Biosciences, Gordon & Breach Publishers, Netherlands, 1996, pp. 111-121.

4504. W.D. Ensminger, J.W. Gyves, P. Stetson, S. Walker-Andrews, “Phase I study of hepatic arterial degradable starch microspheres and mitomycin,” Cancer Res. 45(September 1985):4464-4467; J.W. Gyves, W.D. Ensminger, D. VanHarken, J. Niederhuber, P. Stetson, S. Walker, “Improved regional selectivity of hepatic arterial mitomycin by starch microspheres,” Clin. Pharmacol. Ther. 34(August 1983):259-265; S. Dakhil, W. Ensminger, K. Cho, J. Niederhuber, K. Doan, R. Wheeler, “Improved regional selectivity of hepatic arterial BCNU with degradable microspheres,” Cancer 50(15 August 1982):631-635.

4505. N. Hasegawa, I. Kondo, “Isolation and virulence of a caseinase- and bound coagulase-deficient mutant of Staphylococcus aureus BB,” J. Infect. Dis. 149(April 1984):538-543. See also: C. Bogni, M. Segura, J. Giraudo, A. Giraudo, A. Calzolari, R. Nagel, “Avirulence and immunogenicity in mice of a bovine mastitis Staphylococcus aureus mutant,” Can. J. Vet. Res. 62(October 1998):293-298.

4506. P. Blanc, R. Carbajal, A. Paupe, R. Lenclen, S. Couderc, M. Olivier-Martin, “Water intoxication following preparation for barium enema,” Arch. Pediatr. 2(September 1995):871-873. In French.

4507. Maxine A. Papadakis, “Chapter 20. Fluid and Electrolyte Disorders,” in Lawrence M. Tierney, Jr., Stephen J. McPhee, Maxine A. Papadakis, eds., Current Medical Diagnosis and Treatment, 35th Edition, Appleton and Lange, Stamford, CT, 1996, pp. 768-794.

4508. A.I. Arieff, B.A. Kronlund, “Fatal child abuse by forced water intoxication,” Pediatrics 103(June 1999):1292-1295.

4509. D.M. Gillum, S.L. Linas, “Water intoxication in a psychotic patient with normal renal water excretion,” Am. J. Med. 77(October 1984):773-774.

4510. D.C. Klonoff, A.H. Jurow, “Acute water intoxication as a complication of urine drug testing in the workplace,” JAMA 265(2 January 1991):84-85.

4511. S.G. Richardson, K.B. Matthews, J.K. Cruickshank, A.M. Geddes, J. Stuart, “Coagulation activation and hyperviscosity in infection,” Br. J. Haematol. 42(July 1979):469-480.

4512. J.F. Stoltz, M. Donner, A. Larcan, “Introduction to hemorheology: theoretical aspects and hyperviscosity syndromes,” Int. Angiol. 6(April-June 1987):119-132.

4513. G.D. Lowe, “Blood rheology in vitro and in vivo,” Baillieres Clin. Haematol. 1(September 1987):597-636.

4514. B.M. Coull, N. Beamer, P. de Garmo, G. Sexton, F. Nordt, R. Knox, G.V. Seaman, “Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke,” Stroke 22(February 1991):162-168.

4515. C.K. Arthur, D. McCallum, D.J. Loveday, A. Collins, J.P. Isbister, M.M. Fisher, “Effects of taipan (Oxyuranus scutellatus) venom on erythrocyte morphology and blood viscosity in a human victim in vivo and in vitro,” Trans. R. Soc. Trop. Med. Hyg. 85(May-June 1991):401-403.

4516. W.H. Reinhart, O. Lutolf, U.R. Nydegger, F. Mahler, P.W. Straub, “Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenstrom and multiple myeloma: influence on blood rheology and the microcirculation,” J. Lab. Clin. Med. 119(January 1992):69-76; M.R. MacKenzie, T.K. Lee, “Blood viscosity in Waldenstrom macroglobulinemia,” Blood 49(April 1977):507-510.

4517. A.A. Famodu, O. Oviawe, O. Falodun, “Haemorrheological changes in asthmatic Nigerian children,” Haematologia (Budap) 26(1994):117-119.

4518. J.H. Drew, R.L. Guaran, M. Cichello, J.B. Hobbs, “Neonatal whole blood hyperviscosity: the important factor influencing later neurologic function is the viscosity and not the polycythemia,” Clin. Hemorheol. Microcirc. 17(January-February 1997):67-72; J.H. Drew, R.L. Guaran, S. Grauer, J.B. Hobbs, “Cord whole blood hyperviscosity: measurement, definition, incidence and clinical features,” J. Paediatr. Child Health 27(December 1991):363-365.

4519. N. Antonova, I. Velcheva, “Hemorheological disturbances and characteristic parameters in patients with cerebrovascular disease,” Clin. Hemorheol. Microcirc. 21(1999):405-408.

4520. L. Nobili, G. Schiavi, E. Bozano, F. De Carli, F. Ferrillo, F. Nobili, “Morning increase of whole blood viscosity in obstructive sleep apnea syndrome,” Clin. Hemorheol. Microcirc. 22(2000):21-27.

4521. A.M. Cohen, A. Gelvan, A. Yarmolovsky, M. Djaldetti, “Chorea in polycythemia vera: a rare presentation of hyperviscosity,” Blut 58(January 1989):47-48.

4522. S. Fujioka, “Rheological study on vascular occlusion and cellular hyperviscosity syndrome in polycythemia vera,” Nippon Ketsueki Gakkai Zasshi 52(July 1989):688-695.

4523. A.J. Erslev, “Secondary polycythemia (erythrocytosis),” in E. Beutler, M.A. Lichtman, B.S. Coller, T.J. Kipps, eds., Williams Hematology, Fifth Edition, McGraw-Hill, New York, 1995, pp. 714-726.

4524. S.E. Bergentz, “What is the significance of ‘blood sludge’ today – cause or effect of disease?” Vox Sang. 32(1977):250-256; H. Schmid-Schonbein, G. Gallasch, E. Volger, H.J. Klose, “Microrheology and protein chemistry of pathological red cell aggregation (blood sludge) studies in vitro,” Biorheology 10(June 1973):213-227.

4525. R.L. Replogle, “The nature of blood sludging, and its relationship to the pathophysiological mechanisms of trauma and shock,” J. Trauma 9(August 1969):675-683.

4526. R. Hettich, U. Hopt, “Blood sludging in the burned skin,” Bibl. Anat. 18(1979):363-366.

4527. B. Strohecker, C.J. Parulski, “Frostbite injuries of the hand,” Plast. Surg. Nurs. 17(Winter 1997):212-216.

4528. N.J. Strachan, I.D. Ogden, “A sensitive microsphere coagulation ELISA for Escherichia coli O157:H7 using Russell’s viper venom,” FEMS Microbiol. Lett. 186(1 May 2000):79-84.

4529. K. Lote, “Temporary ischaemia induced by degradable starch microspheres. Possible thrombogenic effects in vivo and in vitro,” Acta Radiol. Oncol. 20(1981):91-96.

4530. Z. Zhang, M. Al-Rubeai, C.R. Thomas, “Estimation of disruption of animal cells by turbulent capillary flow,” Biotechnology and Bioengineering 42(1993):987-993.

4531. M.R. Wabl, R.B. Brun, L. Du Pasquier, “Lymphocytes of the toad Xenopus laevis have the gene set for promoting tadpole development,” Science 190(26 December 1975):1310-1312; M. Zalokar, “Micro-injection by thermal expansion,” Microsc. Acta 84(May 1981):231-237; P. Collas, F.L. Barnes, “Nuclear transplantation by microinjection of inner cell mass and granulosa cell nuclei,” Mol. Reprod. Dev. 38(July 1994):264-267; K. Hosaka, S. Ohi, A. Ando, M. Kobayashi, K. Sato, “Cloned mice derived from somatic cell nuclei,” Hum. Cell 13(December 2000):237-242.

4532. Geert W. Schmid-Schonbein, “Chapter 13: Rheology of Leukocytes,” in Richard Skalak, Shu Chien, eds., Handbook of Bioengineering, McGraw-Hill, New York, 1987.

4533. Julio E. Celis, “Microinjection of somatic cells with micropipettes: comparison with other transfer techniques,” Biochem. J. 223(1984):281-291.

4534. G.S. Worthen, P.M. Henson, S. Rosengren, G.P. Downey, D.M. Hyde, “Neutrophils increase volume during migration in vivo and in vitro,” Am. J. Respir. Cell Mol. Biol. 10(January 1994):1-7.

4535. R.S. Sohal, H. Donato Jr., “Effect of experimental prolongation of life span on lipofuscin content and lysosomal enzyme activity in the brain of the housefly, Musca domestica,” J. Gerontol. 34(July 1979):489-496.

4536. A.B. Basson, S.E. Terblanche, W. Oelofsen, “A comparative study on the effects of ageing and training on the levels of lipofuscin in various tissues of the rat,” Comp. Biochem. Physiol. A 71(1982):369-374.

4537. W.A. Moore, V.A. Davey, R. Weindruch, R. Walford, G.O. Ivy, “The effect of caloric restriction on lipofuscin accumulation in mouse brain with age,” Gerontology 41(1995):173-185 (Suppl 2); M. Nakano, S. Gotoh, “Accumulation of cardiac lipofuscin depends on metabolic rate of mammals,” J. Gerontol. 47(July 1992):B126-B129.

4538. W. Reichel, J. Hollander, J.H. Clark, B.L. Strehler, “Lipofuscin pigment accumulation as a function of age and distribution in rodent brain,” J. Gerontol. 23(January 1968):71-78.

4539. D.M.A. Mann, P.O. Yates, “Lipoprotein pigments – their relationship to ageing in the human nervous system. I. The lipofuscin content of nerve cells,” Brain 97(September 1974):481-488.

4540. A.A. Hidayat, C.E. Margo, J.A. Mauriello Jr., I. North, “Lipofuscinosis of the cornea. A clinicopathologic study of three cases,” Ophthalmology 99(December 1992):1796-1804.

4541. Bernard L. Strehler, Donald D. Mark, Albert S. Mildvan, Malcolm V. Gee, “Rate and magnitude of age pigment accumulation in the human myocardium,” Journal of Gerontology 14(1959):430-439.

4542. Christopher West, “A quantitative study of lipofuscin accumulation with age in normals and individuals with Down’s syndrome, phenylketonuria, progeria and transneuronal atrophy,” J. Comp. Neurol. 186(1 July 1979):109-116.

4543. T.J. James, S.P. Sharma, “Regional and lobular variation in neuronal lipofuscinosis in rat cerebellum: influence of age and protein malnourishment,” Gerontology 41(1995):213-228 (Suppl 2).

4544. C. Roffe, “Ageing of the heart,” Br. J. Biomed. Sci. 55(June 1998):136-148.

4545. L.M. Drach, J. Bohl, H.H. Goebel, “The lipofuscin content of the inferior olivary nucleus in Alzheimer’s disease,” Dementia 5(September-October 1994):234-239.

4546. G.B. McHolm, M.J. Aguilar, F.H. Norris, “Lipofuscin in amyotrophic lateral sclerosis,” Arch. Neurol. 41(November 1984):1187-1188.

4547. I. Davies, A. Fotheringham, C. Roberts, “The effect of lipofuscin on cellular function,” Mech. Ageing Dev. 23(November-December 1983):347-356.

4548. V. Shotelersuk, W.A. Gahl, “Hermansky-Pudlak syndrome: models for intracellular vesicle formation,” Mol. Genet. Metab. 65(October 1998):85-96.

4549. N.A. Shepherd, P.R. Crocker, A.P. Smith, D.A. Levison, “Exogenous pigment in Peyer’s patches,” Hum. Pathol. 18(January 1987):50-54; J.J. Powell, C.C. Ainley, R.S. Harvey, I.M. Mason, M.D. Kendall, E.A. Sankey, A.P. Dhillon, R.P. Thompson, “Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue,” Gut 38(March 1996):390-395.

4550. T.J. Triomphe, “Glycogen storage disease: a basic understanding and guide to nursing care,” J. Pediatr. Nurs. 12(August 1997):238-249.

4551. P.S. Kim, P. Arvan, “Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones,” Endocr. Rev. 19(April 1998):173-202.

4552. D. Jones, V.K. Bhatia, T. Krausz, G.S. Pinkus, “Crystal-storing histiocytosis: a disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain,” Hum. Pathol. 30(December 1999):1441-1448.

4553. B. Winchester, A. Vellodi, E. Young, “The molecular basis of lysosomal storage diseases and their treatment,” Biochem. Soc. Trans. 28(February 2000):150-154.

4554. R.E. Pagano, V. Puri, M. Dominguez, D.L. Marks, “Membrane traffic in sphingolipid storage diseases,” Traffic. 1(November 2000):807-815.

4555. P. Westermark, E. Wilander, “The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus,” Diabetologia 15(November 1978):417-421.

4556. M.C. Beckerle, “Microinjected fluorescent polystyrene beads exhibit saltatory motion in tissue culture cells,” J. Cell Biol. 98(June 1984):2126-2132.

4557. G. Kellner-Weibel, P.G. Yancey, W.G. Jerome, T. Walser, R.P. Mason, M.C. Phillips, G.H. Rothblat, “Crystallization of free cholesterol in model macrophage foam cells,” Arterioscler. Thromb. Vasc. Biol. 19(August 1999):1891-1898;

4558. D. Farge, M.W. Turner, D.R. Roy, S. Jothy, “Dyazide-induced reversible acute renal failure associated with intracellular crystal deposition,” Am. J. Kidney Dis. 8(December 1986):445-449.

4559. L.C. Dijkgraaf, R.S. Liem, L.G. de Bont, G. Boering, “Calcium pyrophosphate dihydrate crystal deposition disease,” Osteoarthritis Cartilage 3(March 1995):35-45.

4560. Tanja Klaus, Ralph Joerger, Eva Olsson, and Claes-Göran Granqvist, “Silver-based crystalline nanoparticles, microbially fabricated,” Proc. Natl. Acad. Sci. (USA) 96(23 November 1999):13611-13614; 96(7 December 1999):14183-14185 (comment).

4561. E.D. Bateman, R.J. Emerson, P.J. Cole, “A study of macrophage-mediated initiation of fibrosis by asbestos and silica using a diffusion chamber technique,” Br. J. Exp. Pathol. 63(August 1982):414-425.

4562. F. Krombach, S. Munzing, A.M. Allmeling, J.T. Gerlach, J. Behr, M. Dorger, “Cell size of alveolar macrophages: an interspecies comparison,” Environ. Health Perspect. 105(September 1997):1261-1263 (Suppl 5).

4563. Y. Kubota, S. Takahashi, O. Matsuoka, “Dependence on particle size in the phagocytosis of latex particles by rabbit alveolar macrophages cultured in vitro,” J. Toxicol. Sci. 8(August 1983):189-195.

4564. B.E. Lehnert, Y.E. Valdez, G.L. Tietjen, “Alveolar macrophage-particle relationships during lung clearance,” Am. J. Respir. Cell Mol. Biol. 1(August 1989):145-154.

4565. H.L. Mueller, B. Robinson, B.A. Muggenburg, N.A. Gillett, R.A. Guilmette, “Particle distribution in lung and lymph node tissues of rats and dogs and the migration of particle-containing alveolar cells in vitro,” J. Toxicol. Environ. Health 30(July 1990):141-165.

4566. G. Oberdorster, J. Ferin, P.E. Morrow, ‘Volumetric loading of alveolar macrophages (AM): a possible basis for diminished AM-mediated particle clearance,” Exp. Lung Res. 18(January-March 1992):87-104.

4567. B.E. Lehnert, P.E. Morrow, “Association of 59iron oxide with alveolar macrophages during alveolar clearance,” Exp. Lung Res. 9(1985):1-16.

4568. John C. Lay, William D. Bennett, Chong S. Kim, Robert B. Devlin, Philip A. Bromberg, “Retention and intracellular distribution of instilled iron oxide particles in human alveolar macrophages,” Am. J. Respir. Cell Mol. Biol. 18(May 1998):687-695.

4569. B. Lewczuk, B. Przybylska-Gornowicz, “The effect of continuous darkness and illumination on the function and the morphology of the pineal gland in the domestic pig. Part II: The effect on pinealocyte ultrastructure,” Neuroendocrinol. Lett. 21(2000):293-299.

4570. D.L. Atkins, J.K. Rosenthal, P.A. Krumm, W.J. Marvin Jr., “Application of stereological analysis of cell volume to isolated myocytes in culture with and without adrenergic innervation,” Anat. Rec. 231(October 1991):209-217.

4571. J.B. Delcarpio, W.C. Claycomb, R.L. Moses, “Ultrastructural morphometric analysis of cultured neonatal and adult rat ventricular cardiac muscle cells,” Am. J. Anat. 186(December 1989):335-345.

4572. E. Lampert, B. Mettauer, H. Hoppeler, A. Charloux, A. Charpentier, J. Lonsdorfer, “Skeletal muscle response to short endurance training in heart transplant recipients,” J. Am. Coll. Cardiol. 32(August 1998):420-426; S.A. Jubrias, P.C. Esselman, L.B. Price, M.E. Cress, K.E. Conley, “Large energetic adaptations of elderly muscle to resistance and endurance training,” J. Appl. Physiol. 90(May 2001):1663-1670; C.M. Tyler, L.C. Golland, D.L. Evans, D.R. Hodgson, R.J. Rose, “Skeletal muscle adaptations to prolonged training, overtraining and detraining in horses,” Pflugers Arch. 436(August 1998):391-397; D.L. Turner, H. Hoppeler, H. Claassen, P. Vock, B. Kayser, F. Schena, G. Ferretti, “Effects of endurance training on oxidative capacity and structural composition of human arm and leg muscles,” Acta Physiol. Scand. 161(December 1997):459-464.

4573. X. Dennett, H.J. Fry, “Overuse syndrome: a muscle biopsy study,” Lancet 1(23 April 1988):905-908.

4574. S. Hashimoto, R.S. Kimura, “Computer-aided three-dimensional reconstruction and morphometry of the outer hair cells of the guinea pig cochlea,” Acta Otolaryngol. 105(January-February 1988):64-74.

4575. U.N. Lanham, “The Blochmann bodies: hereditary intracellular symbionts of insects,” Biol. Rev. Camb. Philos. Soc. 43(August 1968):269-286.

4576. W. Schwemmler, “Endocytobiosis: general principles,” Biosystems 12(1980):111-122.

4577. D. Corsaro, D. Venditti, M. Padula, M. Valassina, “Intracellular life,” Crit. Rev. Microbiol. 25(1999):39-79.

4578. I. Fridovich, “Evidence for the symbiotic origin of mitochondria,” Life Sci. 14(1 March 1974):819-826; L. Margulis, “Symbiotic theory of the origin of eukaryotic organelles: criteria for proof,” Symp. Soc. Exp. Biol. 29(1975):21-38; D. Yang, Y. Oyaizu, H. Oyaizu, G.J. Olsen, C.R. Woese, “Mitochondrial origins,” Proc. Natl. Acad. Sci. (USA) 82(July 1985):4443-4447; M.W. Gray, G. Burger, B.F. Lang, “Mitochondrial evolution,” Science 283(5 March 1999):1476-1481; C.G. Kurland, S.G. Andersson, “Origin and evolution of the mitochondrial proteome,” Microbiol. Mol. Biol. Rev. 64(December 2000):786-820.

4579. J.A. Lake, M.C. Rivera, “Was the nucleus the first endosymbiont?” Proc. Natl. Acad. Sci. (USA) 91(12 April 1994):2880-2881.

4580. T.I. Ahn, K.W. Jeon, “Growth and electron microscopic studies on an experimentally established bacterial endosymbiosis in amoebae,” J. Cell Physiol. 98(January 1979):49-57; K.W. Jeon, “The large, free-living amoebae: wonderful cells for biological studies,” J. Eukaryot. Microbiol. 42(January-February 1995):1-7.

4581. J.H. Werren, D.M. Windsor, “Wolbachia infection frequencies in insects: Evidence of global equilibrium?” Proc. R. Soc. Lond. B. Biol. Sci. 267(7 July 2000):1277-1285.

4582. S.R. Bordenstein, F.P. O’Hara, J.H. Werren, “Wolbachia-induced incompatibility precedes other hybrid incompatibilities in Nasonia,” Nature 409(8 February 2001):707-710, 675-677 (comment).

4583. J.H. Werren, J.D. Bartos, “Recombination in Wolbachia,” Curr. Biol. 11(20 March 2001):431-435; R. Stouthamer, J.A. Breeuwer, G.D. Hurst, “Wolbachia pipientis: microbial manipulator of arthropod reproduction,” Annu. Rev. Microbiol. 53(1999):71-102; S.P. Sinkins, H.R. Braig, S.L. O’Neill, “Wolbachia superinfections and the expression of cytoplasmic incompatibility,” Proc. R. Soc. Lond. B. Biol. Sci. 261(22 September 1995):325-330; L.D. Hurst, “The evolution of cytoplasmic incompatibility or when spite can be successful,” J. Theoret. Biol. 148(21 January 1991):269-277.

4584. Dennis A. Carson, “Chapter 94. Composition and biochemistry of lymphocytes and plasma cells,” in Ernest Beutler, Marshall A. Lichtman, Barry S. Coller, Thomas J. Kipps, eds., William’s Hematology, Fifth Edition, McGraw-Hill, New York, 1995, pp. 916-921.

4585. A.D. Doerman, “Lysis and lysis inhibition with Escherichia coli bacteriophage,” J. Bacteriol. 55(1948):257-275.

4586. Lubert Stryer, Biochemistry, Second Edition, W.H. Freeman & Co., San Francisco, CA, 1981.

4587. Airborne Pathogen Database, “Bacteria: Mycobacterium tuberculosis,” Aerobiological Engineering Series, Penn State Architectural Engineering and Biology Departments;

4588. Amy L. Decatur, Daniel A. Portnoy, “A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity,” Science 290(3 November 2000):992-995.

4589. K. Fujiwara, K. Takahashi, K. Shirota, K.J. Huang, M. Nakayama, “Fine pathology of mouse spinal cord infected with the Tyzzer organism,” Jpn. J. Exp. Med. 51(June 1981):171-178.

4590. T. Hackstadt, “The biology of rickettsiae,” Infect. Agents Dis. 5(June 1996):127-143.

4591. C. Magowan, J.T. Brown, N. Mohandas, W. Meyer-Ilse, “X-ray microscopy of human malaria,” 1995;

4592. Abdul Ghaffar, “Parasitology – Lecture Two: Blood and Tissue Protozoa,” Microbiology and Immunology On-Line, MBIM 650/720 Medical Microbilogy – Lecture: 81-82, University of South Caroline, 18 June 2001;

4593. C.T. Atkinson, E.C. Greiner, D.J. Forrester, “Pre-erythrocytic development and associated host responses to Haemoproteus meleagridis (Haemosporina: Haemoproteidae) in experimentally infected domestic turkeys,” J. Protozool. 33(August 1986):375-381.

4594. A.O. Heydorn, H. Mehlhorn, “Fine structure of Sarcocystis arieticanis Heydorn, 1985 in its intermediate and final hosts (sheep and dog),” Zentralbl. Bakteriol. Mikrobiol. Hyg. A 264(May 1987):353-362.

4595. Z. Abd-Al-Aal, N.F. Ramadan, A. Al-Hoot, “Life-cycle of Isospora mehlhornii sp. Nov. (Apicomplexa: Eimeriidae), parasite of the Egyptian swallow Hirundo rubicola savignii,” Parasitol. Res. 86(April 2000):270-278.

4596. L. Allen, “On the penetrability of the lymphatics of the diaphragm,” Anat. Record 124(1956):639-652.

4597. Y.C. Fung, Biodynamics: Circulation, Springer-Verlag, New York, 1984.

4598. D. Broekaert, “Cytoskeletal polypeptides: cell-type specific markers useful in investigative otorhinolaryngology,” Int. J. Pediatr. Otorhinolaryngol. 27(May 1993):1-20.

4599. W.C. Grinstead, G.P. Rodgers, W. Mazur, B.A. French, D. Cromeens, C. Van Pelt, S.M. West, A.E. Raizner, “Comparison of three porcine restenosis models: the relative importance of hypercholesterolemia, endothelial abrasion, and stenting,” Coron. Artery Dis. 5(May 1994):425-434.


Last updated on 16 April 2004